Sun, Feb 1, 2015, 6:53 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • levonchiko levonchiko Apr 18, 2013 9:29 AM Flag

    Insmed to Present at the 12th Annual Needham Healthcare Conference

    http://finance.yahoo.com/news/insmed-present-12th-annual-needham-120000804.html
    MONMOUTH JUNCTION, NJ--(Marketwired - Apr 18, 2013) - Insmed Incorporated (NASDAQ: INSM), a biopharmaceutical company focused on developing and commercializing inhaled therapies for patients battling serious lung diseases in orphan indications that are often life-threatening, today announced Will Lewis, President and Chief Executive Officer of Insmed, will be presenting a corporate overview at the 12th Annual Needham Healthcare Conference taking place at the Westin Grand Central in New York City from April 30-May 1, 2013. Mr. Lewis' presentation will take place at 3:00 p.m. on April 30th.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • http://finance.yahoo.com/news/insmed-present-12th-annual-needham-120000804.html
      MONMOUTH JUNCTION, NJ--(Marketwired - Apr 18, 2013) - Insmed Incorporated (NASDAQ: INSM), a biopharmaceutical company focused on developing and commercializing inhaled therapies for patients battling serious lung diseases in orphan indications that are often life-threatening, today announced Will Lewis, President and Chief Executive Officer of Insmed, will be presenting a corporate overview at the 12th Annual Needham Healthcare Conference taking place at the Westin Grand Central in New York City from April 30-May 1, 2013. Mr. Lewis' presentation will take place at 3:00 p.m. on April 30th

 
INSM
15.46-0.50(-3.13%)Jan 30 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.